Learn about prostate cancer, its diagnosis, treatment options, and the latest study findings. Understand which types need ...

When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...

There may be a "promising new strategy" in combating aggressive forms of prostate cancer, according to a new study. Researchers at Flinders University and the University of South Australia ...

Better short-term survival with apalutamide versus darolutamide, but lots of unanswered qu ...

These results suggest that oxybutynin may offer a practical and effective option for managing ADT-associated hot flashes in ...

The phase 2b study is an open-label trial that will enroll 40 men with advanced prostate cancer who are appropriate candidates for ADT. Participants will receive an initial loading dose of teverelix ...

Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the immune system.

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain ...

Oxybutynin, a common drug to manage overactive bladder, may help alleviate hot flash symptoms among men receiving androgen ...

Breakthrough for prostate cancer patients as NHS now offers life-extending drug - The new medication is suitable for patients who are unable to receive chemotherapy or standard treatments ...

Relief for men experiencing the challenges of Benign Prostatic Hyperplasia (BPH), or prostate enlargement, has arrived with the introduction of Flowel and Flowel Plus by Superior Pharmaceuticals ...

We urgently need research to understand the factors driving ethnic inequalities in prostate cancer outcomes, say Habib Naqvi ...